Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    8955
    PDF: 6007
    HTML: 87920
    Fig.1b: 172
    Fig.1c: 171
    Fig.2a: 164
    Fig.2b: 163
    Fig.4: 175
    Fig.2c: 170
    Fig.3: 169
    Tab.1: 215
    Tab.2: 194
    Tab.3: 180
    Tab.4: 207
    Fig1a: 165
  • Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

    Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi
    e2016060
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.060
    3154
    PDF: 754
    HTML: 2929
    Figure 1a and 1b: 139
    Figure 2: 146
    Figure 3: 167
    Figure 4: 147
    Figure 5: 151
    Tables 1-5: 144
  • GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.

    Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
    e2015041
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.041
    2158
    PDF: 1008
    HTML: 1179
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2198
    PDF: 1769
    HTML: 132
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    2768
    PDF: 1017
    HTML: 294
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1568
    PDF: 792
    HTML: 149
  • CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Rafael de la Camara
    e2016031
    2016-06-20
    https://doi.org/10.4084/mjhid.2016.031
    4737
    PDF: 1733
    HTML: 2692
    Untitled: 199
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    2842
    PDF: 862
    HTML: 1388
  • Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

    Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
    e2022025
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.025
    1735
    PDF: 552
    HTML: 269
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

    Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava
    e2011056
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.056
    3585
    PDF: 902
    HTML: 4437
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2093
    PDF: 714
    HTML: 1620
  • CLINICAL FEATURES AND CLINICAL OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED AT CAIRO NATIONAL CANCER INSTITUTE IN EGYPT

    Ola Khorshid, Amira Diaa, Mohamed Abd El Moaty, Rafat Abd El Fatah, Ihab El Dessouk, Maha Abd El Hamid, Essam El Noshokaty, Ghada El Saied, Tamer M Fouad, Safaa M Ramadan
    e2011060
    2011-12-07
    https://doi.org/10.4084/mjhid.2011.060
    2991
    PDF: 919
    HTML: 2282
  • CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

    Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori
    e2019048
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.048
    1894
    PDF: 1140
    HTML: 258
  • OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia

    Erika Borlenghi, Tatiana Zollner, Giuseppe Rossi, Chiara Pagani, Michele Malagola, Alessandra Sottini, Diego Bertoli, Mariella Tonelli, Marco Chiarini, Chiara Cattaneo, Rossella Leopaldo, Angela Passi, Lorenzo Masina, Francesca Federico, Carlotta Giupponi, Alessandra Tucci
    e2024080
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.080
    1267
    PDF: 554
    Suppl. Files: 340
    HTML: 133
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1504
    PDF: 1173
    HTML: 173
  • PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Isidro Jarque, Miguel Salavert, Javier Pemán
    e2016035
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.035
    3651
    PDF: 1217
    HTML: 3872
    Untitled: 195
    Untitled: 244
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1650
    PDF: 733
    HTML: 474
  • NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal Berivan Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karakas, Veysel Sabri Hancer
    e2023036
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.036
    817
    PDF: 688
    HTML: 256
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1254
    PDF: 597
    HTML: 3064
  • Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma

    Martina Canichella, Stefano Fratoni, Carla Mazzone, alice di rocco, elisabetta abruzzese
    e2026014
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.014
    698
    PDF: 639
    Html: 122
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1386
    PDF: 1365
    HTML: 176
  • WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

    Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi
    e2018004
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.004
    7353
    PDF: 2385
    HTML: 1713
    Table 1.: 190
    Table 2.: 204
    Table 3.: 185
    Table 4.: 183
  • DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Prosenjit Ganguli
    e2014004
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.004
    1429
    PDF: 890
    HTML: 2198
    Response to reviewers comments: 164
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1255
    PDF: 722
    HTML: 1391
  • ASSOCIATION BETWEEN LEUKEMIC EVOLUTION AND UNCOMMON CHROMOSOMAL ALTERATIONS IN PEDIATRIC MYELODYSPLASTIC SYNDROME

    Viviane Lamim Lovatel, Beatriz Ferreira da Silva , Eliane Ferreira Rodrigues , Maria Luiza Rocha da Rosa Borges , Rita de Cássia Barbosa Tavares, Ana Paula Silva Bueno, Elaine Sobral da Costa, Terezinha de Jesus Marques , Teresa de Souza Fernandez
    e2024003
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.003
    1147
    PDF: 1357
    HTML: 121
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1860
    PDF: 990
    HTML: 1326
  • TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

    Agustin Avilès, Maria-Jesus Nambo, Natividad Neri
    e2018006
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.006
    3508
    PDF: 1045
    HTML: 869
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    1976
    PDF: 1043
    HTML: 1187
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1233
    PDF: 518
    HTML: 23019
  • TYROSINE KINASE INHIBITORS AND PREGNANCY

    Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti
    e2014028
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.028
    3470
    PDF: 1603
    HTML: 2665
  • EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA

    Li Zhang, Xiaofan Zhu
    e2012012
    2012-03-10
    https://doi.org/10.4084/mjhid.2012.012
    2225
    PDF: 818
    HTML: 2123
    New table Chinese children with APL: 152
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1480
    PDF: 865
    HTML: 104
  • FLUDARABINE-BASED LOW-INTENSITY CONDITIONING FOR FANCONI ANEMIA IS ASSOCIATED WITH GOOD OUTCOMES IN APLASTIC ANEMIA BUT NOT IN MDS - A SINGLE-CENTER EXPERIENCE

    Biju George, Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Devasia, Anu Korula, Uday Kulkarni, Fouzia Aboobacker, Eunice Sindhuvi, Kavitha Lakshmi, Alok Srivastava, Aby Abraham, Vikram Mathews
    e2023039
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.039
    1251
    PDF: 956
    HTML: 295
  • MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

    Xiaoling Ma
    e2020012
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.012
    1627
    PDF: 1014
    HTML: 193
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    725
    PDF: 459
    HTML: 74
  • Bacillus Cereus catheter related bloodstream infection in a patient in a patient with acute lymphblastic leukemia

    Lütfiye Öksüz, N Gurler, M Muftuoglu, FD Sargin, SK Besisik
    e2012004
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.004
    1551
    PDF: 1069
    HTML: 1063
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3274
    PDF: 1220
    HTML: 2184
  • THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

    Evi Stavrou, Hillard Michael Lazarus
    e2010033
    2010-10-29
    https://doi.org/10.4084/mjhid.2010.033
    1543
    PDF: 1030
    HTML: 10433
  • Breastfeeding in patients with chronic myeloid leukaemia: case series with measurements of drug concentrations in maternal milk and review of literature

    Ekaterina Chelysheva, Sergey Aleshin, Evgenia Polushkina, Roman Shmakov, Igor Shokhin, Ghermes Chilov, Anna Turkina
    e2018027
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.027
    3081
    PDF: 968
    HTML: 340
  • EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES

    Kjeld Schmiegelow
    e2011020
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.020
    2160
    PDF: 782
    HTML: 1614
    Figure 1: 170
    Table 1: 190
  • PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?

    Kalliopi Zachou, Pinelopi Arvaniti, Nikolaos K. Gatselis, Kalliopi Azariadis, Georgia Papadamou, Eirini Rigopoulou, George N. Dalekos
    e2017003
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.003
    2900
    PDF: 953
    HTML: 2053
    Cover letter: 165
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1664
    PDF: 1100
    HTML: 267
  • OUTCOME OF CANDIDA PARAPSILOSIS COMPLEX INFECTIONS TREATED WITH CASPOFUNGIN IN CHILDREN

    İlker Devrim, Rana İşgüder, Hasan Ağın, Nuri Bayram, Gökhan Ceylan, Yüce Ayhan, Özlem Saraç Sandal, Ferhat Sarı, Ahu Kara, Mine Düzgöl
    e2016042
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.042
    3580
    PDF: 748
    HTML: 834
  • Utility of flow cytometry ascitic fluid analysis for rapid diagnosis of B-cell peritoneal lymphomatosis

    Maria Laura Bisegna, Niccolò Noccioli, Irene Della Starza, Alice Di Rocco, Nadia Peragine, Maria Stefania De Propris
    e2022068
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.068
    720
    PDF: 462
    HTML: 284
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3221
    PDF: 1606
    HTML: 1489
  • CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA

    Alessandro Bartoloni, Lorenzo Zammarchi
    e2012026
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.026
    7789
    PDF: 4054
    HTML: 7319
  • IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

    Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi
    e2017010
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.010
    3333
    PDF: 1256
    HTML: 2202
    Fi.1 Gritti.Rambaldi: 192
  • RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC

    Rawanda Shamoon, Ahmed K. Yassin, Sara L. Alnuaimi
    e2024019
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.019
    1011
    PDF: 1135
    HTML: 68
  • NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

    Alessandro Corso, Silvia Mangiacavalli
    e2017053
    2017-08-18
    https://doi.org/10.4084/mjhid.2017.053
    3195
    PDF: 1692
    HTML: 1075
  • CYTOKINE RESPONSE ASSOCIATED WITH HEPATITIS C VIRUS CLEARANCE IN HIV COINFECTED PATIENTS INITIATING PEG INTERFERON-? BASED THERAPY.

    Truong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, Kuster Nils, Karine Bollore, Jacques Ducos, Georges-Philippe Pageaux, Jacques Reynes, Philippe Van de Perre, Edouard Tuaillon
    e2016003
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.003
    3097
    PDF: 866
    HTML: 2035
    Untitled: 167
101 - 150 of 324 items << < 1 2 3 4 5 6 7 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy